Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ORTHOPEDIATRICS CORP.

(KIDS)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/26/2021 07/27/2021 07/28/2021 07/29/2021 07/30/2021 Date
59.97(c) 61.08(c) 60.26(c) 60.6(c) 62.84(c) Last
47 425 64 659 65 095 36 987 66 745 Volume
-2.52% +1.85% -1.34% +0.56% +3.70% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 96,2 M - -
Net income 2021 -29,5 M - -
Net Debt 2021 - - -
P/E ratio 2021 -41,2x
Yield 2021 -
Sales 2022 116 M - -
Net income 2022 -13,1 M - -
Net Debt 2022 - - -
P/E ratio 2022 -87,9x
Yield 2022 -
Capitalization 1 235 M 1 235 M -
Capi. / Sales 2021 12,8x
Capi. / Sales 2022 10,7x
Nbr of Employees 116
Free-Float 69,7%
More Financials
Company
OrthoPediatrics Corp. is a medical device company focused on providing product offerings to the pediatric orthopedic market for children with orthopedic conditions. The Company designs, develops and commercializes orthopedic implants and instruments to meet the specialized needs of pediatric surgeons and their patients. The Company operates through the OrthoPediatrics segment, which designs, develops and markets... 
More about the company
Ratings of OrthoPediatrics Corp.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
D
More Ratings
All news about ORTHOPEDIATRICS CORP.
07/29ORTHOPEDIATRICS : Maintains its Diamond Sponsorship for 31st Annual Baltimore Li..
AQ
07/22OrthoPediatrics Corp. to Report Second Quarter 2021 Financial Results on Augu..
GL
06/25ORTHOPEDIATRICS CORP.(NASDAQGM : KIDS) dropped from Russell 2000 Defensive Index
CI
06/25ORTHOPEDIATRICS CORP.(NASDAQGM : KIDS) dropped from Russell 2000 Growth-Defensiv..
CI
06/14ORTHOPEDIATRICS : Needham Adjusts OrthoPediatrics' Price Target to $77 From $70,..
MT
06/10OrthoPediatrics Corp. Announces Launch of Next Generation Cannulated Screw Sy..
GL
06/10OrthoPediatrics Corp. Announces Launch of Next Generation Cannulated Screw Sy..
CI
06/09OrthoPediatrics Corp. to Present at the 2021 JMP Securities Life Sciences Con..
GL
06/03ORTHOPEDIATRICS CORP : Submission of Matters to a Vote of Security Holders (form..
AQ
06/03ORTHOPEDIATRICS : Names David Bailey as New CEO
MT
06/03OrthoPediatrics Corp. Completes Senior Leadership Transition with Appointment..
GL
05/28ORTHOPEDIATRICS : Launches RESPONSE™ Neuromuscular Scoliosis System (Form ..
PU
05/28ORTHOPEDIATRICS CORP : Regulation FD Disclosure, Financial Statements and Exhibi..
AQ
05/28OrthoPediatrics Corp. Launches RESPONSE™ Neuromuscular Scoliosis System
GL
05/28Orthopediatrics Corp. Announces the Launch of Its Response™ Neuromuscular Sco..
CI
More news
News in other languages on ORTHOPEDIATRICS CORP.

- No features available -

More news
Analyst Recommendations on ORTHOPEDIATRICS CORP.
More recommendations
Chart ORTHOPEDIATRICS CORP.
Duration : Period :
OrthoPediatrics Corp. Technical Analysis Chart | KIDS | US68752L1008 | MarketScreener
Technical analysis trends ORTHOPEDIATRICS CORP.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Last Close Price 62,84 $
Average target price 70,83 $
Spread / Average Target 12,7%
EPS Revisions
Managers and Directors
David R. Bailey President & Chief Executive Officer
Fred L. Hite Director, Chief Operating & Financial Officer
Mark C. Throdahl Executive Chairman
Peter F. Armstrong Chief Medical Officer
Joel Batts Senior Vice President-Science & Technology
Sector and Competitors